The dysregulation of GATA3 is implicated in a wide spectrum of diseases, ranging from cancers, including breast, prostate, and T-cell lymphomas, to autoimmune and neurodegenerative disorders. Here, GATA3 is linked to T-cell non-Hodgkin lymphoma.